Radiopharm Theranostics Ltd.

RADX·NASDAQ·$4.61Share Price as of 11/2·$6MMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)09/30/26 20-F/AAnnual report (foreign, amended)12/10/25 20-FAnnual report (foreign)09/18/25

Disclosures

6-KForeign issuer report10/30/26 6-KForeign issuer report10/27/26 6-KForeign issuer report10/26/26 6-KForeign issuer report10/20/26 6-KForeign issuer report10/05/26

Prospectuses and Registrations

424B3Prospectus09/23/26 F-3Shelf registration (foreign)09/14/26 424B5Prospectus supplement07/27/26 424B5Prospectus supplement07/23/26 424B3Prospectus12/23/25

Proxies

No matching filings.

Ownership

Form 4Insider transaction10/27/26 SC 13GBeneficial ownership10/14/26 SC 13DBeneficial ownership09/04/26 SC 13GBeneficial ownership09/04/26 Form 3Initial insider ownership05/06/26

Other

EFFECTRequest for effectiveness09/23/26 EFFECTRequest for effectiveness12/23/25 EFFECTRequest for effectiveness12/23/25 CORRESPCorrespondence with the SEC12/19/25 CORRESPCorrespondence with the SEC12/19/25